Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Inv. presentation
|
|
Akero Therapeutics, Inc. (AKRO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/11/2023 |
3
| Lamy Patrick (See Remarks) has filed a Form 3 on Akero Therapeutics, Inc. |
| 07/14/2021 |
3
| Judy Chou (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/30/2021 |
3
| Skorpios Trust (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
| 04/26/2021 |
3
| Xu Yuan (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/11/2020 |
3
| Heyman Tomas J. (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Redmile Group, LLC (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| venBio Global Strategic Fund II L.P. (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Atlas Venture Fund XI, L.P. (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Bitterman Kevin (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Young Jonathan (EVP, COO) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| White William Richard (EVP, CFO) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Henderson Jane (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Iwicki Mark T (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Harrison Seth Loring (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Rolph Timothy (Chief Scientific Officer) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Versant Venture Capital VI, L.P. (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Yale Catriona (Chief Development Officer) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Graham G. Walmsley (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Cheng Andrew (President and CEO) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Royston Aaron (Director) has filed a Form 3 on Akero Therapeutics, Inc. |
| 06/19/2019 |
3
| Apple Tree Partners IV, L.P. (10% Owner) has filed a Form 3 on Akero Therapeutics, Inc. |
|
|